Why AI and robotics will define New Health

November 15, 2018

Would you allow a medical robot with artificial intelligence (AI) to examine, diagnose and prescribe a treatment plan for you or a member of your family with cancer? Would you accept a robot as your primary surgeon? And if you were to do so, what would the human clinician do? AI and robots have long been a theme in fiction. From Isaac Asimov’s ‘I, Robot’ in 1950 to Baymax, the care robot in ‘Big Hero 6’, we’ve long been fascinated with the possibilities for machines that can understand, reason and learn – and help us to make better use of information.

Spotlight

Cytiva

Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. As a trusted partner to customers that range in scale and scope, Cytiva brings speed, efficiency, and capacity to research and manufacturing workflows, enabling the development, manufacture, and delivery of transformative medicines to patients. We are 7000+ associates with operations in 40 countries. Our customers are working with fundamental biological research to life-saving vaccines, biological drugs, and novel cell and gene therapies.

OTHER WHITEPAPERS
news image

Managing the Deluge of Payer Integrity Audits

whitePaper | June 7, 2022

In a recent webinar, Dawn Crump, Senior Director of Revenue Cycle Solutions at the Norristown, Pennsylvania-based MRO Corporation, shared her expertise with her virtual audience, around the very important topic of payment integrity audits.

Read More
news image

Increasing Health Equity in Your Community

whitePaper | November 12, 2022

The past two years have seen accelerated adoption and utilization of telehealth services by a majority of healthcare organizations, driven in large part by the COVID-19 pandemic.

Read More
news image

How health systems can recover millions in lost revenue

whitePaper | February 5, 2020

The landscape of healthcare revenue appears bleak: costs and expenses are rising, while reimbursements decline. Traditionally, solutions focus on preventative measures, yet costly write-offs remain ever-present. This is especially true with respect to commercial claims, where denials are plentiful and appeals complicated and labor intensive. How, then, can you mitigate loss without straining your resources? One answer is claims appeals through the Federal ERISA process. Through specialization in Federal ERISA Law, the experienced staff of ERISA Recovery can collect on aged claims without undue burden on your systems.

Read More
news image

Using Clinical Trial Sites’Input to Select the Right Capabilities when Decentralizing Clinical Trials

whitePaper | March 22, 2023

The COVID-19 pandemic has renewed emphasis on innovations to support clinical trial operations. Traditional sites including hospitals and private practices were forced during the height of the pandemic to find novel ways to continue patient care.

Read More
news image

Healthcare Payment Predictions - What You Need To Know

whitePaper | October 1, 2021

Today’s healthcare consumers want to pay their medical bills anywhere, anytime. They’re looking for estimates, payment plan options, and payment mechanisms to be at their fingertips across multiple channels. They can pay for almost anything they desire from their laptops and mobile devices, so why should healthcare be any different? What do providers need to know to build a healthcare payment solution that’s fit for purpose today and into the future? Experian Health’s patient payment experts make seven predictions for healthcare payments that will help providers boost consumer loyalty and revenue.

Read More
news image

A Comparison of Substance Use Disorders before and during theCOVID-19 Pandemic

whitePaper | December 20, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

Read More

Spotlight

Cytiva

Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. As a trusted partner to customers that range in scale and scope, Cytiva brings speed, efficiency, and capacity to research and manufacturing workflows, enabling the development, manufacture, and delivery of transformative medicines to patients. We are 7000+ associates with operations in 40 countries. Our customers are working with fundamental biological research to life-saving vaccines, biological drugs, and novel cell and gene therapies.

Events